CDK7-IN-26
CDK7-IN-26 (compound 36) is an orally active CDK7 inhibitor (IC50: 7.4 nM). CDK7-IN-26 potently inhibits the growth of triple-negative breast cancer (TNBC) cell line-derived xenograft (CDX) tumors in vivo and inhibits MDA-MB-453 cells in vitro with an IC50 of 0.15 μM.
For research use only. We do not sell to patients.
- CAS No.: 3024545-79-4
- Formula: C22H22FN6OPS
- Molecular Weight:468.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
IC50: 7.4 nM (CDK7)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-231 | EC50 |
0.32 μM
Compound: 36
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 120 hrs by CCK-8 assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 120 hrs by CCK-8 assay
|
[PMID: 38000213] |
| MDA-MB-453 | EC50 |
0.15 μM
Compound: 36
|
Antiproliferative activity against human MDA-MB-453 cells incubated for 120 hrs by CCK-8 assay
Antiproliferative activity against human MDA-MB-453 cells incubated for 120 hrs by CCK-8 assay
|
[PMID: 38000213] |
Chemical Information
-
CAS No. 3024545-79-4
-
Molecular Weight 468.49
-
Formula C22H22FN6OPS
-
SMILES
O=P(C)(C1=C(C=CC2=C1NC=C2C3=NC(N[C@H]4C[C@H](F)CNC4)=NC5=C3SC=C5)C#N)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CDK7-IN-26 Related Classifications
HY-157210 Related Classifications
Powered by Bioz